Ivabradine in Patients With an Unsatisfactory Percentage of Cardiac Resynchronization Therapy
Status:
Unknown status
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the role of ivabradine in cardiac resynchronization
recipients with an unsatisfactory percentage biventricular pacing.
The study protocol 60 patients with heart failure NYHA (New York Heart Association) II-IV
treated with optimal medical therapy as clinically indicated who received CRT-D device more
than 3 months ago. Patients with biventricular pacing <95% will and heart rate <70 at rest
and >50% of heart rate in device memory >70 will receive ivabradine. The minimal follow-up of
patients in the study will be at least six months.